article thumbnail

MRI predicts Parkinson's disease progression

AuntMinnie

MRI illuminates the structural and functional organization of the brain -- thus helping clinicians predict the progression of Parkinson's disease in patients in its early stages, researchers have found. Parkinson's disease can manifest as tremors, slowness of movement, or rigidity, and its symptoms worsen over time, according to the RSNA.

Disease 105
article thumbnail

Use of AI opportunistic screening in CT for cardiovascular disease

Health Imaging

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Disease 82
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Brain Connectivity on MRI Predicts Parkinson’s Disease Progression

Imaging Technology

milla1cf Tue, 06/25/2024 - 19:03 June 25, 2024 — The structural and functional organization of the brain as shown on MRI can predict the progression of brain atrophy in patients with early-stage, mild Parkinson’s disease, according to a study published today in Radiology , a journal of the Radiological Society of North America ( RSNA ).

Disease 111
article thumbnail

DMI feasible in Alzheimer’s disease patients

AuntMinnie

Deuterium metabolic imaging (DMI) can reveal impaired brain glucose metabolism in patients with Alzheimer’s disease, according to a study published July 16 in Radiology. Khan and colleagues recruited 10 participants with Alzheimer's disease (mean age, 68 years old, eight males) and nine cognitively healthy control participants.

Disease 103
article thumbnail

Employer Insights Report 2024: The State of Cancer

So why is it that 82% of employers currently spend significantly more on post-diagnosis care and disease management rather than upstream care? 96% of benefits leaders agree: detecting cancer early is the best way to get ahead of rising costs and improve employee health outcomes.

article thumbnail

Radiology ‘Game-Changer’: FDA Approves PET Agent for Enhanced Detection of Coronary Artery Disease

Diagnostic Imaging

Offering higher diagnostic efficacy than SPECT imaging for coronary artery disease (CAD) detection, the PET myocardial perfusion imaging agent Flyrcado™ (flurpiridaz F 18, GE HealthCare) provides unit dose availability and effectiveness in imaging patients with high BMI.

Disease 119
article thumbnail

Photon-counting CT emerges as alternative for assessing fatty liver disease

AuntMinnie

Photon-counting CT may serve as an alternative to MRI for assessing liver fat in patients with fatty liver disease, according to an article published September 24 in Radiology. The disease affects up to 24% of the population in the U.S. and can lead to cirrhosis and even cancer if left untreated. (A) in the MASLD cohort.

Disease 111